Results 91 to 100 of about 8,585,360 (297)
Dentistry JournalThe purpose of this randomized, split-mouth-designed controlled and single-blinded clinical study was to evaluate the 3-year clinical performance of Class I and Class II resin composite restorations placed with or without cavity lining with a flowable ...
Anh Duc Nguyen +4 more
doaj +1 more source
A CLINICAL STUDY OF HYPERPHORIA. [PDF]
JAMA: The Journal of the American Medical Association, 1898 The importance of recognizing and correcting with absolute accuracy, any existing error of refraction, has long since become an axiom, a truth too evident to require demonstration. In the past decade, mainly as a result of careful clinical study, errors of muscular balance have been attracting the attention of the ophthalmic surgeon; but in this field ...
openaire +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
[Clinical studies on netilmicin].
The Japanese journal of antibiotics, 1984 Netilmicin (NTL), a new semisynthesized aminoglycoside, was evaluated in 11 episodes of infection in 10 patients, who had severe underlying diseases, such as acute myocardial infarction, cerebral infarction, malignancy and hepatic cirrhosis. The infection was bacteremia in 3 cases, urinary tract infections in 3 cases and respiratory tract infections in
TAKII, MASAHIDE +2 more
openaire +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi +9 more
wiley +1 more source
, 2019 Galunisertib is an anti-cancer drug currently evaluated in phase I and II clinical trials. This study describes the development and validation of a bioanalytical assay to quantify galunisertib in human plasma using HPLC-MS/MS.
Huijberts, S +8 more
core +1 more source
Ganoderma lucidum: a comprehensive review of phytochemistry, efficacy, safety and clinical study
Food Science and Human WellnessGanoderma lucidum, one of the most well-known edible fungi, is believed to be very benef icial for longevity and vitality. A long usage history suggests that G. lucidum has various clinical therapeutic effects.
Sijia Wu +7 more
doaj +1 more source
International Journal of Nanomedicine, 2023 Khaled S Allemailem,1 Mohammed A Alsahli,1 Ahmad Almatroudi,1 Faris Alrumaihi,1 Waleed Al Abdulmonem,2 Amira A Moawad,3 Wanian M Alwanian,1 Nahlah Makki Almansour,4 Arshad Husain Rahmani,1 Amjad Ali Khan5 1Department of Medical Laboratories, College of ...
Allemailem KS +9 more
doaj
GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk
Frontiers in Cardiovascular Medicine, 2017 BackgroundPlatelet membrane glycoprotein receptors mediate thrombus formation. GP Ia/IIa is an essential platelet integrin receptor. Single-nucleotide polymorphisms (SNPs) of the GP Ia/IIa gene alter GP Ia/IIa expression; however, their influence on ...
Dominik Rath +15 more
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Chronic limb‐threatening ischemia (CLTI) is a severe form of lower‐extremity artery disease characterized by distal lesions and microcirculatory impairment, limiting revascularization efficacy. Rheocarna is a direct hemoperfusion low‐density lipoprotein (LDL) adsorption device with potential rheological and anti‐inflammatory ...
Kunihiro Ishioka +12 more
wiley +1 more source